Daidzein and genistein fail to improve glycemic control and insulin sensitivity in Chinese women with impaired glucose regulation: A double-blind, randomized, placebo-controlled trial

Molecular Nutrition and Food Research

Volumn 59, Issue 2, 2015, Pages 240-249

  Ye, Yan Bin ^a,b   Chen, Ai Ling ^a   Lu, Wei ^a   Zhuo, Shu Yu ^a   Liu, Juan ^a   Guan, Jian Hua ^c   Deng, Wan Ping ^a   Fang, Shi ^a   Li, Yan Bing ^a   Chen, Yu Ming ^b  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU UNIVERSITY   (China)

Author keywords

Daidzein; Genistein; Glycemic control; Insulin sensitivity; Soy isoflavones

Indexed keywords

DAIDZEIN; GENISTEIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; INSULIN; ISOFLAVONE DERIVATIVE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GENISTEIN; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; ISOFLAVONES; MIDDLE AGED; MOTOR ACTIVITY; TREATMENT OUTCOME;

EID: 84922706350     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400390     Document Type: Article

References (45)

1. Whiting, D. R., Guariguata, L., Weil, C., Shaw, J., IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract. 2011, 94, 311-321.
2. Yang, W., Lu, J., Weng, J., Jia, W. et al., Prevalence of diabetes among men and women in China. N. Engl. J. Med. 2010, 362, 1090-1101.
3. Alberti, K. G., Zimmet, P., Shaw, J., International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet. Med. 2007, 24, 451-463.
4. Bartke, A., Peluso, M. R., Moretz, N., Wright, C. et al., Effects of Soy-derived diets on plasma and liver lipids, glucose tolerance, and longevity in normal, long-lived and short-lived mice. Horm. Metab. Res. 2004, 36, 550-558.
5. Lu, M. P., Wang, R., Song, X., Chibbar, R. et al., Dietary soy isoflavones increase insulin secretion and prevent the development of diabetic cataracts in streptozotocin-induced diabetic rats. Nutr. Res. 2008, 28, 464-471.
6. Mezei, O., Banz, W. J., Steger, R. W., Peluso, M. R. et al., Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J. Nutr. 2003, 133, 1238-1243.
7. Yu, Z. W., Eriksson, J. W., The upregulating effect of insulin and vanadate on cell surface insulin receptors in rat adipocytes is modulated by glucose and energy availability. Horm. Metab. Res. 2000, 32, 310-315.
8. Villegas, R., Gao, Y. T., Yang, G., Li, H. L. et al., Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am. J. Clin. Nutr. 2008, 87, 162-167.
9. Mueller, N. T., Odegaard, A. O., Gross, M. D., Koh, W. P. et al., Soy intake and risk of type 2 diabetes in Chinese Singaporeans [corrected]. Eur. J. Nutr. 2012, 51, 1033-1040.
10. Morimoto, Y., Steinbrecher, A., Kolonel, L. N., Maskarinec, G., Soy consumption is not protective against diabetes in Hawaii: the Multiethnic Cohort. Eur. J. Clin. Nutr. 2011, 65, 279-282.
11. Nanri, A., Mizoue, T., Takahashi, Y., Kirii, K. et al., Soy product and isoflavone intakes are associated with a lower risk of type 2 diabetes in overweight Japanese women. J. Nutr. 2010, 140, 580-586.
12. Ricci, E., Cipriani, S., Chiaffarino, F., Malvezzi, M. et al., Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: a meta-analysis of randomized controlled trials. Menopause 2010, 17, 1080-1086.
13. Liu, Z. M., Chen, Y. M., Ho, S. C., Effects of soy intake on glycemic control: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2011, 93, 1092-1101.
14. Villa, P., Costantini, B., Suriano, R., Perri, C. et al., The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status. J. Clin. Endocrinol. Metab. 2009, 94, 552-558.
15. Chen, S. T., Chen, J. R., Yang, C. S., Peng, S. J. et al., Effect of soya protein on serum lipid profile and lipoprotein concentrations in patients undergoing hypercholesterolaemic haemodialysis. Br. J. Nutr. 2006, 95, 366-371.
16. Wu, A. H., Stanczyk, F. Z., Martinez, C., Tseng, C. C. et al., A controlled 2-mo dietary fat reduction and soy food supplementation study in postmenopausal women. Am. J. Clin. Nutr. 2005, 81, 1133-1141.
17. Jayagopal, V., Albertazzi, P., Kilpatrick, E. S., Howarth, E. M. et al., Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 2002, 25, 1709-1714.
18. Liu, Z. M., Chen, Y. M., Ho, S. C., Ho, Y. P. et al., Effects of soy protein and isoflavones on glycemic control and insulin sensitivity: a 6-mo double-blind, randomized, placebo-controlled trial in postmenopausal Chinese women with prediabetes or untreated early diabetes. Am. J. Clin. Nutr. 2010, 91, 1394-1401.
19. Gobert, C. P., Pipe, E. A., Capes, S. E., Darlington, G. A. et al., Soya protein does not affect glycaemic control in adults with type 2 diabetes. Br. J. Nutr. 2010, 103, 412-421.
20. Okabe, Y., Shimazu, T., Tanimoto, H., Higher bioavailability of isoflavones after a single ingestion of aglycone-rich fermented soybeans compared with glucoside-rich non-fermented soybeans in Japanese postmenopausal women. J. Sci. Food Agric. 2011, 91, 658-663.
21. Izumi, T., Piskula, M. K., Osawa, S., Obata, A. et al., Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J. Nutr. 2000, 130, 1695-1699.
22. Weaver, C. M., Cheong, J. M., Soy isoflavones and bone health: the relationship is still unclear. J. Nutr. 2005, 135, 1243-1247.
23. Morabito, N., Crisafulli, A., Vergara, C., Gaudio, A. et al., Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study. J. Bone Miner. Res. 2002, 17, 1904-1912.
24. Marini, H., Minutoli, L., Polito, F., Bitto, A. et al., Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial. Ann. Intern. Med. 2007, 146, 839-847.
25. Szkudelska, K., Nogowski, L., Genistein-a dietary compound inducing hormonal and metabolic changes. J. Steroid Biochem. Mol. Biol. 2007, 105, 37-45.
26. Lavigne, C., Marette, A., Jacques, H., Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am. J. Physiol. Endocrinol. Metab. 2000, 278, E491-E500.
27. Choi, M. S., Jung, U. J., Yeo, J., Kim, M. J. et al., Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab. Res. Rev. 2008, 24, 74-81.
28. Crisafulli, A., Altavilla, D., Marini, H., Bitto, A. et al., Effects of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women. Menopause 2005, 12, 186-192.
29. Atteritano, M., Marini, H., Minutoli, L., Polito, F. et al., Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 2007, 92, 3068-3075.
30. Marini, H., Bitto, A., Altavilla, D., Burnett, B. P. et al., Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a follow-up study. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 332-340.
31. Setchell, K. D. R., Brown, N. M., Lydeking-Olsen, E., The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J. Nutr. 2002, 132, 3577-3584.
32. Setchell, K. D., Clerici, C., Lephart, E. D., Cole, S. J. et al., S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. Am. J. Clin. Nutr. 2005, 81, 1072-1079.
33. Yang, Y. X. (Ed.), China Food Composition. Peking University Medical Press, Beijing, China 2004.
34. Guo, K., Zhang, B., Chen, C., Uchiyama, S. et al., Daidzein-metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China. Br. J. Nutr. 2010, 104, 118-124.
35. Ho, S. C., Chen, Y. M., Ho, S. S., Woo, J. L., Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Menopause 2007, 14, 905-912.
36. Franke, A. A., Lai, J. F., Halm, B. M., Pagano, I. et al., Equol production changes over time in postmenopausal women. J. Nutr. Biochem. 2012, 23, 573-579.
37. Mohamad-Shahi, M., Karandish, M., Haidari, F., Omidian, K. et al., Effect of daidzein-low-calorie diet on body weight, serum levels of glucose, resistin, and high sensitive C-reactive protein in high fat, high calorie diet induced rats. Saudi Med. J. 2012, 33, 70-75.
38. Yang, G., Shu, X. O., Jin, F., Elasy, T. et al., Soyfood consumption and risk of glycosuria: a cross-sectional study within the Shanghai Women's Health Study. Eur. J. Clin. Nutr. 2004, 58, 615-620.
39. Yang, B., Chen, Y., Xu, T., Yu, Y. et al., Systematic review and meta-analysis of soy products consumption in patients with type 2 diabetes mellitus. Asia Pac. J. Clin. Nutr. 2011, 20, 593-602.
40. Zhang, Y. B., Chen, W. H., Guo, J. J., Fu, Z. H. et al., Soy isoflavone supplementation could reduce body weight and improve glucose metabolism in non-Asian postmenopausal women-a meta-analysis. Nutrition 2013, 29, 8-14.
41. Squadrito, F., Marini, H., Bitto, A., Altavilla, D. et al., Genistein in the metabolic syndrome: results of a randomized clinical trial. J. Clin. Endocrinol. Metab. 2013, 98, 3366-3374.
42. Khaodhiar, L., Ricciotti, H. A., Li, L., Pan, W. et al., Daidzein-rich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause 2008, 15, 125-132.
43. Jackson, R. L., Greiwe, J. S., Schwen, R. J., Emerging evidence of the health benefits of S-equol, an estrogen receptor beta agonist. Nutr. Rev. 2011, 69, 432-448.
44. Usui, T., Tochiya, M., Sasaki, Y., Muranaka, K. et al., Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin. Endocrinol. 2013, 78, 365-372.
45. Shahbazian, H., Reza, A., Javad, S., Heshmatollah, S. et al., Beneficial effects of soy protein isoflavones on lipid and blood glucose concentrations in type 2 diabetic subjects. Saudi Med. J. 2007, 28, 652-654.